Search clinical trials for: ferric citrate

Total 1832 results

Rockwell Medical Technologies, Inc.

Not yet recruiting

Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy

Iron Deficiency Anemia
University of California, Los Angeles
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Ferric Citrate and Chronic Kidney Disease in Children (FIT4KID)

Chronic Kidney Diseases

United States, Canada
Keryx Biopharmaceuticals

Not yet recruiting

Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Keryx Biopharmaceuticals

Recruiting

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Hyperphosphatemia Related to Chronic Kidney Disease

United States
Rockwell Medical Technologies, Inc.

Recruiting

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

End Stage Renal Disease

United States, Puerto Rico
Sinomune Pharmaceutical Co., Ltd

Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

End Stage Renal Disease | ESRD | Hyperphosphatemia

China
USRC Kidney Research
Akebia Therapeutics

Active, not recruiting

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease (FRONTIER)

Disease Progression | Renal Insufficiency, Chronic | Hyperphosphatemia | Anemia, Iron Deficiency | Renal Anemia | Iron | Cardiovascular

United States
Winthrop University Hospital
Keryx Biopharmaceuticals

Terminated

A Study of Ferric Citrate to Improve Inflammation and Lipid Levels

End Stage Renal Disease | Chronic Inflammation | Hyperphosphatemia

United States
Panion & BF Biotech Inc.

Completed

PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

Anemia of Chronic Kidney Disease

Taiwan
Ardelyx

Completed

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

Hyperphosphatemia

United States
USRC Kidney Research
Akebia Therapeutics Inc.

Completed

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants (IMPACT)

Renal Insufficiency | Hyperphosphatemia | Anemia, Iron Deficiency

United States
Emory University
Novartis

Terminated

Phase II Study of Everolimus Beyond Progression

Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer

United States
Kaiser Permanente
Keryx Biopharmaceuticals

Completed

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Swiss Federal Institute of Technology
Jomo Kenyatta University of Agriculture and Technology

Completed

Evaluation of the Effects of Routine Iron Supplementation in Children on Gastrointestinal Iron Losses

Iron-deficiency | Iron Deficiency Anemia | Gastro Intestinal Bleeding

Kenya
Rockwell Medical Technologies, Inc.

Completed

Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

End Stage Renal Disease

United States
Keryx Biopharmaceuticals

Completed

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) (COMPASS)

Chronic Kidney Diseases | Iron Deficiency Anemia

United States
Panion & BF Biotech Inc.
Shandong Weigao Panion Pharmaceutical Co. Ltd.

Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

End Stage Renal Disease | ESRD | Hyperphosphatemia

China
Rockwell Medical Technologies, Inc.

Completed

A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Terminated

Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol

Iron-Refractory Iron-Deficiency Anemia
University of Alabama at Birmingham

Completed

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency

Anemia | Chronic Kidney Disease | Iron Deficiency

United States
Panion & BF Biotech Inc.

Completed

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

Kidney Failure, Chronic | Hyperphosphatemia | Phosphorus Metabolism Disorders | End-stage Renal Disease

Taiwan
Panion & BF Biotech Inc.

Completed

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

End Stage Renal Disease | ESRD | Hyperphosphatemia

Taiwan
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers (RMFPC-12)

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

Anemia | Chronic Kidney Disease | Peritoneal Dialysis (PD)
Sreedhar Mandayam
Keryx Biopharmaceuticals

Active, not recruiting

Ferric Citrate in ESRD Pilot Project

Chronic Kidney Diseases | End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers

Iron-refractory, Iron-deficiency Anemia (IRIDA)

United States
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Triferic Pediatric Pharmacokinetic Protocol

End Stage Renal Disease

United States
Keryx Biopharmaceuticals

Completed

A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

Anemia of Chronic Kidney Disease

Israel
Denver Nephrologists, P.C.
Keryx Biopharmaceuticals

Completed

Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D (05D)

Renal Insufficiency | Chronic Kidney Disease | Iron Deficiency Anemia | Hyperphosphatemia

United States
Keryx Biopharmaceuticals

Completed

KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

Anemia of Chronic Kidney Disease

United States
Keryx Biopharmaceuticals

Completed

Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

Iron Deficiency Anemia | Iron Deficiency

United States
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)

Hyperphosphatemia | End-stage Renal Disease

United States
Swiss Federal Institute of Technology
University for Development Studies, Tamale, Ghana

Completed

Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Zinc, Citric Acid/Trisodium Citrate and EDTA (MM_Rice)

Iron Deficiency and/or Anemia

Switzerland, Ghana
Rockwell Medical Technologies, Inc.

Completed

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

End Stage Renal Disease | Chronic Kidney Disease

United States, Canada
Keryx Biopharmaceuticals

Completed

A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

Renal Failure | End Stage Renal Disease | ESRD | Kidney Failure | Hyperphosphatemia

United States, Puerto Rico
Mark Frye
University of California, Los Angeles

Withdrawn

Can Additional Drug Therapy Accelerate Response Time to Antidepressants

Depression

United States
Swiss Federal Institute of Technology

Completed

Iron Absorption From Rice Fortified With Ferric Pyrophosphate

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Keryx Biopharmaceuticals

Completed

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

Kidney Failure | Hyperphosphatemia

United States, Israel, Puerto Rico
Keryx Biopharmaceuticals

Completed

Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Hyperphosphatemia | End-stage Renal Disease | Renal Failure Chronic Requiring Hemodialysis

Israel
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

End-Stage Renal Disease | Hyperphosphatemia

United States, Puerto Rico
Enzon Pharmaceuticals, Inc.

Terminated

A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

Liver Transplantation

United States
Seoul St. Mary's Hospital

Not yet recruiting

The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy (Ferritin)

Pancreaticojuodenectomy
Ruijin Hospital

Not yet recruiting

Effect of Oxycodone on Anxiety State in Painless Abortion

Abortion Complication
Hospital de Clinicas de Porto Alegre
Vifor Pharma

Not yet recruiting

IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency (COMBINED-HF)

Heart Failure, Systolic | Iron Deficiencies

Brazil
China-Japan Friendship Hospital

Recruiting

The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency (IRONDOSE)

Heart Failure | Iron Deficiency

China
Abramson Cancer Center at Penn Medicine

Not yet recruiting

FAPI-74 PET/CT in Adults With Fibrosis

Fibrosis (Morphologic Abnormality)

United States
Semmelweis University

Recruiting

The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrate (NEOKOFF22)

Premature Birth | Respiratory Failure | Apnea of Prematurity

Hungary
TC Erciyes University

Recruiting

Effect of Different Irrigation Solutions on Postoperative Pain and Lesion Healing

Endodontic Disease

Turkey

Search clinical trials for: ferric citrate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations